Clinical Trials Logo

Clinical Trial Summary

This study evaluates the non-inferiority of a protocol of limited evaluation (complete blood count, blood culture) and clinical observation by standardized physical examination versus the algorithm suggested in the CDC's 2010 guidelines (limited evaluation, clinical observation and antibiotic therapy) in the management of asymptomatic infants born at term to mothers with suspected chorioamnionitis. The primary outcome of the study is the difference in the prevalence of sepsis-related symptoms between the two groups.


Clinical Trial Description

Chorioamnionitis complicates 1-3% of pregnancies at term. The current international guidelines of the Center for Disease Control (CDC 2010) recommend that all asymptomatic newborns born to mothers with suspected chorioamnionitis undergo limited evaluation (i.e. blood culture at birth and complete blood count) and antibiotic therapy until the blood culture result is available.

However, the prevalence of positive blood cultures in infants born to mothers with suspected chorioamnionitis is low, approximately 1%, including also infants requiring intensive care. This prevalence is even lower in asymptomatic infants. Moreover, the efficacy of antibiotic prophylaxis in preventing early sepsis, death or long-term sequelae in asymptomatic infants born to mothers with suspected chorioamnionitis has not been demonstrated.

Early antibiotic use has been related to obesity and to the modification of microbiota. Limiting antibiotic use may prevent the emergence of antibiotic-resistant bacteria.

Clinical observation is a reliable method to recognize infants with sepsis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02886910
Study type Interventional
Source IRCCS Burlo Garofolo
Contact
Status Withdrawn
Phase N/A
Start date October 2016
Completion date November 2019

See also
  Status Clinical Trial Phase
Terminated NCT05603624 - Effect of Sterile Versus Clean Gloves Intrapartum and Postpartum Infections at Term N/A
Terminated NCT03320785 - Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
Completed NCT01633294 - Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term Phase 2/Phase 3
Recruiting NCT00299637 - Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis Phase 0
Completed NCT00153517 - Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy Phase 2
Completed NCT00397735 - N-acetylcysteine in Intra-amniotic Infection/Inflammation Phase 1/Phase 2
Completed NCT00814905 - Treatment of Chorioamnionitis After Delivery N/A
Completed NCT01852188 - Intrapartum Study of Sterile and Clean Gloves N/A
Completed NCT00879190 - Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis Phase 2/Phase 3
Recruiting NCT04307069 - Management of Prelabor Rupture of the Membranes at Term N/A
Withdrawn NCT03168178 - Intrapartum Fever: Antibiotics Versus no Treatment Phase 4
Completed NCT03576560 - Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis
Completed NCT00185991 - Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis N/A
Completed NCT00070746 - Perinatal Infections in Pakistan N/A
Completed NCT03636698 - Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway
Not yet recruiting NCT01778725 - Early Identification of Brain Insult in Chorioamnionitis N/A
Recruiting NCT01988168 - Closure of Skin in ChorioAmnionitis Research Pilot Study N/A
Completed NCT04651309 - Assessment of Labour Progress by Intrapartum Ultrasound N/A
Completed NCT00724594 - Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio) Phase 1/Phase 2